Summit Therapeutics Inc. Common Stock
SMMT •
Buy Open
Signal type
Buy
Status
Open
Open Price
$19.85
Stop Loss
$17.69
Performance
5.04%
Days Open
13
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 2, 2026
Open Price $19.85
Stop Loss $17.69
Timespan Day
Company Profile
Name Summit Therapeutics Inc. Common Stock
Ticker SMMT
Market Cap $15.74B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $20.85
List Date Mar 5, 2015
Description
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Website Open Company Website